International consensus on diagnosing and managing pancreatic serous and mucinous cystic neoplasms

In 2023, with the approval of the leadership of the Hepato-Pancreato-Biliary Association of Commonwealth of Independent States, a consensus study was initiated and conducted on the diagnosis, management, and follow-up of patients with serous and mucinous neoplasms of the pancreas. Based on an extensive literature review, responses to each of the 22 questions posed were formulated and compiled into a Consensus Document. A total of 44 experts representing 27 institutions across 9 countries participated in the preparation of the Consensus. The Delphi method was employed for voting, and ultimately, including the results of votes on selected statements during the final conference, consensus was achieved on all questions.

1. Udare A., Agarwal M., Alabousi M., McInnes M., Rubino J.G., Marcaccio M., van der Pol C.B. Diagnostic accuracy of MRI for differentiation of benign and malignant pancreatic cystic lesions compared to CT and endoscopic ultrasound: systematic review and meta-analysis. J. Magn. Reson. Imaging. 2021; 54 (4): 1126–1137. https://doi.org/10.1002/jmri.27606

2. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018; 67 (5): 789–804. https://doi.org/10.1136/gutjnl-2018-316027

3. Tanaka M., Chari S., Adsay V., Fernandez-del Castillo C., Falconi M., Shimizu M., Yamaguchi K., Yamao K., Matsuno S. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6 (1–2): 17–32. https://doi.org/10.1159/000090023

4. Li Y.J., Lee G.H., Yang M.J., Hwang J.C., Yoo B.M., Kim S.S., Lim S.G., Kim J.H. Diagnostic yield of transabdominal ultrasonography for evaluation of pancreatic cystic lesions compared with endoscopic ultrasonography. J. Clin. Med. 2021; 10 (19): 4616. https://doi.org/10.3390/jcm10194616

5. Cheung T.T., Lee Y.T., Tang R.S., She W.H., Cheng K.C., Cheung C.C., Chiu K.W.H., Chok K.S.H., Chow W.S., Lai T.W., Seto W.K., Yau T. The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions. Hepatobiliary Surg. Nutr. 2023; 12 (5): 715–735. https://doi.org/10.21037/hbsn-22-471

6. Mamone G., Barresi L., Tropea A., Di Piazza A., Miraglia R. MRI of mucinous pancreatic cystic lesions: a new updated morphological approach for the differential diagnosis. Updates Surg. 2020; 72 (3): 617–637. https://doi.org/10.1007/s13304-020-00800-y

7. Kriger A.G., Panteleev V.I., Dzhigkaeva M.M., Budzinskiy S.A. Pancreatic mucinous cystadenoma with atypical clinical presentation. Pirogov Russian Journal of Surgery. 2023; 12: 118–122. https://doi.org/10.17116/hirurgia2023121118 (In Russian)

8. Shabunin A.V., Tavobilov М.М., Karpov A.A., Paklina О.V., Setdikova G.R., Ivanova N.A., Ozerova D.S. Acinar cell cystadenoma of the pancreatic head. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2020; 25 (2): 145–151. https://doi.org/10.16931/1995-5464.20202145-151 (In Russian)

9. Pollini T., Marchegiani G., Facciorusso A., Balduzzi A., Biancotto M., Bassi C., Maker A.V., Salvia R. It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy. HPB (Oxford). 2023; 25 (7): 747–757. https://doi.org/10.1016/j.hpb.2023.03.001

10. Marchegiani G., Balduzzi A., Pollini T., Caravati A., Biancotto M., Andrianello S., Zampese M., Bassi C., Salvia R. The use of a mobile application to disseminate guidelines on cystic neoplasms of the pancreas – a snapshot study of 1000 case-simulations. Pancreatology. 2021; 21 (8): 1472–1475. https://doi.org/10.1016/j.pan.2021.09.009

11. Sahora K., Mino-Kenudson M., Brugge W., Thayer S.P., Ferrone C.R., Sahani D., Pitman M.B., Warshaw A.L., Lillemoe K.D., Fernandez-del Castillo C.F. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann. Surg. 2013; 258 (3): 466–475. https://doi.org/10.1097/SLA.0b013e3182a18f48

12. Ohtsuka T., Fernandez-del Castillo C., Furukawa T., Hijioka S., Jang J., Lennon A.M., Miyasaka Y., Ohno E., Salvia R., Wolfgang C.L., Wood L.D. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024; 24 (2): 255–270. https://doi.org/10.1016/j.pan.2023.12.009

13. Listone H.A., Turoff M. The Delphi method: techniques and applications. J. Marketing Res. 1975; 18 (3). https://doi.org/10.2307/3150755

14. Spinelli K.S., Fromwiller T.E., Daniel R.A., Kiely J.M., Nakeeb A., Komorowski R.A., Wilson S.D., Pitt H.A. Cystic pancreatic neoplasms: observe or operate. Ann. Surg. 2004; 239 (5): 651–657; discussion 657–659. https://doi.org/10.1097/01.sla.0000124299.57430.ce

15. Hashimoto S., Hirooka Y., Kawabe N., Nakaoka K., Yoshioka K. Role of transabdominal ultrasonography in the diagnosis of pancreatic cystic lesions. J. Med. Ultrason. (2001). 2020; 47 (3): 389–399. https://doi.org/10.1007/s10396-019-00975-x

16. Zerboni G., Signoretti M., Crippa S., Falconi M., Arcidiacono P.G., Capurso G. Systematic review and metaanalysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology. 2019; 19 (1): 2–9. https://doi.org/10.1016/j.pan.2018.11.014

17. Putzer D., Jaschke W. Radiological evaluation of focal pancreatic lesions. Dig. Dis. 2015; 33 (1): 91–98. https://doi.org/10.1159/000366045

18. Okasha H.H., Awad A., El-Meligui A., Ezzat R., Aboubakr A., AbouElenin S., El-Husseiny R., Alzamzamy A. Cystic pancreatic lesions, the endless dilemma. World J. Gastroenterol. 2021; 27 (21): 2664–2680. https://doi.org/10.3748/wjg.v27.i21.2664

19. Pandey P., Pandey A., Luo Y., Aliyari Ghasabeh M., Khoshpouri P., Ameli S., O'Broin-Lennon A.M., Canto M., Hruban R.H., Goggins M.S., Wolfgang C., Kamel I.R. Follow-up of incidentally detected pancreatic cystic neoplasms: do baseline MRI and CT features predict cyst growth? Radiology. 2019; 292 (3): 647–654. https://doi.org/10.1148/radiol.2019181686

20. Laffan T.A., Horton K.M., Klein A.P., Berlanstein B., Siegelman S.S., Kawamoto S., Johnson P.T., Fishman E.K., Hruban R.H. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am. J. Roentgenol. 2008; 191 (3): 802–807. https://doi.org/10.2214/AJR.07.3340

21. Sahani D.V., Kambadakone A., Macari M., Takahashi N., Chari S., Fernandez-del Castillo C. Diagnosis and management of cystic pancreatic lesions. AJR Am. J. Roentgenol. 2013; 200 (2): 343–354. https://doi.org/10.2214/AJR.12.8862

22. Chaudhari V.V., Raman S.S., Vuong N.L., Zimmerman P., Farrell J., Reber H., Sayre J., Lu D.S. Pancreatic cystic lesions: discrimination accuracy based on clinical data and high resolution CT features. J. Comput. Assist. Tomogr. 2007; 31 (6): 860–867. https://doi.org/10.1097/RCT.0b013e318039b277

23. Karsenti D., Gincul R., Belle A., Vienne A., Weiss E., Vanbiervliet G., Gronier O. Antibiotic prophylaxis in digestive endoscopy: Guidelines from the French Society of Digestive Endoscopy. Endosc. Int. Open. 2024; 12 (10): E1171–E1182. https://doi.org/10.1055/a-2415-9414

24. de Jong K., Nio C.Y., Mearadji B., Phoa S.S., Engelbrecht M.R., Dijkgraaf M.G., Bruno M.J., Fockens P. Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging. Pancreas. 2012; 41 (2): 278–282. https://doi.org/10.1097/MPA.0b013e31822899b6

25. Kloth C., Haggenmüller B., Beck A., Wagner M., Kornmann M., Steinacker J.P., Steinacker-Stanescu N., Vogele D., Beer M., Juchems M.S. Diagnostic, structured classification and therapeutic approach in cystic pancreatic lesions: systematic findings with regard to the European guidelines. Diagnostics (Basel). 2023; 13 (3): 454. https://doi.org/10.3390/diagnostics13030454

26. van Huijgevoort N.C.M., Del Chiaro M., Wolfgang C.L., van Hooft J.E., Besselink M.G. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat. Rev. Gastroenterol. Hepatol. 2019; 16 (11): 676–689. https://doi.org/10.1038/s41575-019-0195-x

27. Mohamed E., Jackson R., Halloran C.M., Ghaneh P. Role of radiological imaging in the diagnosis and characterization of pancreatic cystic lesions: a systematic review. Pancreas. 2018; 47 (9): 1055–1064. https://doi.org/10.1097/MPA.0000000000001134

28. Zhang Y., Wu J., He J., Xu S. Preoperative differentiation of pancreatic cystic neoplasm subtypes on computed tomography radiomics. Quant. Imaging Med. Surg. 2023; 13 (10): 6395–6411. https://doi.org/10.21037/qims-22-1192

29. de Moura D.T.H., Ryou M., de Moura E.G.H., Ribeiro I.B., Bernardo W.M., Thompson C.C. Endoscopic ultrasoundguided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary strictures: a meta-analysis of same-session procedures. Clin. Endosc. 2020; 53 (4): 417–428. https://doi.org/10.5946/ce.2019.053

30. Sobhrakhshankhah E., Sohrabi M., Norouzi H.R., Zamani F., Ajdarkosh H., Nikkhah M., Khoonsari M.R., Faraji A.H. Tissue sampling through endoscopic ultrasound-guided fine needle aspiration versus endoscopic retrograde cholangiopancreatographic brushing cytology technique in suspicious malig-nant biliary stricture. Middle East J. Dig. Dis. 2021; 13 (4): 294–301. https://doi.org/10.34172/mejdd.2021.238

31. Zhu H., Jiang F., Zhu J., Du Y., Jin Z., Li Z. Assessment of morbidity and mortality associated with endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions: a systematic review and meta-analysis. Dig. Endosc. 2017; 29 (6): 667–675. https://doi.org/10.1111/den.12851

32. Yang D., Trindade A.J., Yachimski P., Benias P., Nieto J., Manvar A., Ho S., Esnakula A., Gamboa A., Sethi A., Gupte A., Khara H.S., Diehl D.L., El Chafic A., Shah J., Forsmark C.E., Draganov P.V. Histologic analysis of endoscopic ultrasoundguided through the needle microforceps biopsies accurately identifies mucinous pancreas cysts. Clin. Gastroenterol. Hepatol. 2019; 17 (8): 1587–1596. https://doi.org/10.1016/j.cgh.2018.11.027

33. Wang Q.X., Xiao J., Orange M., Zhang H., Zhu Y.Q. EUSguided FNA for diagnosis of pancreatic cystic lesions: a metaanalysis. Cell Physiol. Biochem. 2015; 36 (3): 1197–1209. https://doi.org/10.1159/000430290

34. Mohapatra S., Krishna S.G., Pannala R. Pancreatic cystic neoplasms: translating guidelines into clinical practice. Diagnostics (Basel). 2023; 13 (4): 749. https://doi.org/10.3390/diagnostics13040749

35. Kovalenko D.D., Parfenchikova E.V., Shchadrova V.V., Noskova K.K., Rakhmetova L.Y., Orlova M.V., Gusarova O.A. Difficulties in Diagnosing solid Pseudopapillary Neoplasia of the Pancreas. Effective Pharmacotherapy. 2024; 20 (46): 88–93. https://doi.org/10.33978/2307-3586-2024-20-46-88-93 (In Russian)

36. Thornton G.D., McPhail M.J., Nayagam S., Hewitt M.J., Vlavianos P., Monahan K.J. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology. 2013; 13 (1): 48–57. https://doi.org/10.1016/j.pan.2012.11.313

37. Layfield L.J., Ehya H., Filie A.C., Hruban R.H., Jhala N., Joseph L., Vielh P., Pitman M.B. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines. Cytojournal. 2014; 11 (Suppl. 1): 4. https://doi.org/10.4103/1742-6413.133352

38. Khan I., Baig M., Bandepalle T., Puli S.R. Utility of cyst fluid carcinoembryonic antigen in differentiating mucinous and non-mucinous pancreatic cysts: an updated meta-analysis. Dig. Dis. Sci. 2022; 67 (9): 4541–4548. https://doi.org/10.1007/s10620-021-07315-5

39. Kazmi S.Z., Jung H.S., Han Y., Yun W.G., Cho Y.J., Lee M., Kwon W., Castillo C.F., Del Chiaro M., Marchegiani G., Goh B.K.P., Hijioka S., Majumder S., Nakai Y., Shin A., Jang J.Y. Systematic review on surveillance for non-resected branch-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2024; 24 (3): 463–488. https://doi.org/10.1016/j.pan.2024.02.015

40. Guzmán-Calderón E., Md B.M., Casellas J.A., Aparicio J.R. Intracystic glucose levels appear useful for diagnosis of pancreatic cystic lesions: a systematic review and meta-analysis. Dig. Dis. Sci. 2022; 67 (6): 2562–2570. https://doi.org/10.1007/s10620-021-07035-w

41. Lopes C.V. Cyst fluid glucose: an alternative to carcinoembryonic antigen for pancreatic mucinous cysts. World J. Gastroenterol. 2019; 25 (19): 2271–2278. https://doi.org/10.3748/wjg.v25.i19.2271

42. Gorris M., Dijk F., Farina A., Halfwerk J.B., Hooijer G.K., Lekkerkerker S.J., Voermans R.P., Wielenga M.C., Besselink M.G., van Hooft J.E. Validation of combined carcinoembryonic antigen and glucose testing in pancreatic cyst fluid to differentiate mucinous from non-mucinous cysts. Surg. Endosc. 2023; 37 (5): 3739–3746. https://doi.org/10.1007/s00464-022-09822-6

43. McCarty T.R., Paleti S., Rustagi T. Molecular analysis of EUSacquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis. Gastrointest. Endosc. 2021; 93 (5): 1019–1033.e5. https://doi.org/10.1016/j.gie.2020.12.014

44. Singhi A.D., McGrath K., Brand R.E., Khalid A., Zeh H.J., Chennat J.S., Fasanella K.E., Papachristou G.I., Slivka A., Bartlett D.L., Dasyam A.K., Hogg M., Lee K.K., Marsh J.W., Monaco S.E., Ohori N.P., Pingpank J.F., Tsung A., Zureikat A.H., Wald A.I., Nikiforova M.N. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut. 2018; 67 (12): 2131–2141. https://doi.org/10.1136/gutjnl-2016-313586

45. Stepanova Yu.A., Karakhanyan A.A., Shevchenko T.V., Ayvazyan Kh.A., Zhavoronkova O.I., Shirokov V.S., Glotov A.V., Zhao A.V. Hepatic cystadenocarcinoma. erroneous diagnosis leading to a progressive progression of the disease. Vysokotekhnologicheskaya Medicina. 2022; 9 (4): 63–73. (In Russian)

46. Facciorusso A., Del Prete V., Antonino M., Buccino V.R., Wani S. Diagnostic yield of EUS-guided through-the-needle biopsy in pancreatic cysts: a meta-analysis. Gastrointest. Endosc. 2020; 92 (1): 1–8.e3. https://doi.org/10.1016/j.gie.2020.01.038

47. Tacelli M., Celsa C., Magro B., Barchiesi M., Barresi L., Capurso G., Arcidiacono P.G., Cammà C., Crinò S.F. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: systematic review with meta-analysis. Dig. Endosc. 2020; 32 (7): 1018–1030. https://doi.org/10.1111/den.13626

48. Kotelnikov A.G., Abgaryan M.G., Zabezhinsky D.A., Podluzhny D.V., Patyutko Yu.I. Cancer of the Head of the Pancreas: Modern Treatment and Further Prospects. Journal “Herald of surgical gastroenterology”. 2007; 3: 5– 16. (In Russian)

49. Polkowski M., Jenssen C., Kaye P., Carrara S., Deprez P., Gines A., Fernández-Esparrach G., Eisendrath P., Aithal G.P., Arcidiacono P., Barthet M., Bastos P., Fornelli A., Napoleon B., Iglesias-Garcia J., Seicean A., Larghi A., Hassan C., van Hooft J.E., Dumonceau J.M. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – March 2017. Endoscopy. 2017; 49 (10): 989–1006. https://doi.org/10.1055/s-0043-119219

50. Kromrey M.L., Bülow R., Hübner J., Paperlein C., Lerch M.M., Ittermann T., Völzke H., Mayerle J., Kühn J.P. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018; 67 (1): 138–145. https://doi.org/10.1136/gutjnl-2016-313127

51. Karpov O.E., Vetshev P.S., Bruslik S.V., Sviridova T.I., Levchuk A.L., Sarzhevskiy V.O., Sudilovskaya V.V. Ultrasound ablation (HIFU) in the treatment of pancreatic unresectable tumors. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2015; 20 (3): 17–23. https://doi.org/10.16931/1995-5464.2015317-23 (In Russian)

52. Allen P.J., D'Angelica M., Gonen M., Jaques D.P., Coit D.G., Jarnagin W.R., DeMatteo R., Fong Y., Blumgart L.H., Brennan M.F. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann. Surg. 2006; 244 (4): 572–582. https://doi.org/10.1097/01.sla.0000237652.84466.54

53. Scheiman J.M., Hwang J.H., Moayyedi P. American Gastroenterological Association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015; 148 (4): 824–848.e22. https://doi.org/10.1053/j.gastro.2015.01.014

54. Correa-Gallego C., Miyasaka Y., Hozaka Y., Nishino H., Kawamoto M., Vieira D.L., Ohtsuka T., Wolfgang C. Surveillance after resection of non-invasive intraductal papillary mucinous neoplasms (IPMN). A systematic review. Pancreatology. 2023; 23 (3): 258–265. https://doi.org/10.1016/j.pan.2023.02.008

55. Ardeshna D.R., Cao T., Rodgers B., Onongaya C., Jones D., Chen W., Koay E.J., Krishna S.G. Recent advances in the diagnostic evaluation of pancreatic cystic lesions. World J. Gastroenterol. 2022; 28 (6): 624–634. https://doi.org/10.3748/wjg.v28.i6.624

56. Ren R., Krishna S.G., Chen W., Frankel W.L., Shen R., Zhao W., Avenarius M.R., Garee J., Caruthers S., Jones D. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation. Mod. Pathol. 2021; 34 (2): 438–444. https://doi.org/10.1016/j.dld.2020.06.038

57. Thosani N., Thosani S., Qiao W., Fleming J.B., Bhutani M.S., Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig. Dis. Sci. 2010; 55 (10): 2756–2766. https://doi.org/10.1007/s10620-010-1361-8

58. Stelow E.B., Stanley M.W., Bardales R.H., Mallery S., Lai R., Linzie B.M., Pambuccian S.E. Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultrasound-guided fineneedle aspiration. Am. J. Clin. Pathol. 2003; 120 (3): 398–404. https://doi.org/10.1309/CEPK-542W-3885-2LP8

59. Pitman M.B., Centeno B.A., Reid M.D., Siddiqui M.T., Layfield L.J., Perez-Machado M., Weynand B., Stelow E.B., Lozano M.D., Fukushima N., Cree I.A., Mehrotra R., Schmitt F.C., Field A.S. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytol. 2023; 67 (3): 304–320. https://doi.org/10.1159/000527912

60. International Academy of Cytology-International Agency for Research on Cancer-World Health Organization Joint Editorial Board. WHO Reporting System for Pancreaticobiliary Cytopathology. Vol. 2. 1st ed. International Agency for Research on Cancer; 2022. https://doi.org/10.1007/978-92-832-4518-6

61. Vilela A., Quingalahua E., Vargas A., Hawa F., Shannon C., Carpenter E.S., Shi J., Krishna S.G., Lee U.J., Chalhoub J.M., Machicado J.D. Global prevalence of pancreatic cystic lesions in the general population on magnetic resonance imaging: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2024; 22 (9): 1798–1809.e6. https://doi.org/10.1016/j.cgh.2024.02.018

62. Smith A.L., Abdul-Karim F.W., Goyal A. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: a retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathol. 2016; 124 (4): 285–293. https://doi.org/10.1002/cncy.21657

63. Pflüger M.J., Jamouss K.T., Afghani E., Lim S.J., Rodriguez Franco S., Mayo H., Spann M., Wang H., Singhi A., Lennon A.M., Wood L.D. Predictive ability of pancreatic cyst fluid biomarkers: a systematic review and meta-analysis. Pancreatology. 2023; 23 (7): 868–877. https://doi.org/10.1016/j.pan.2023.05.005

64. Hoda R.S., Arpin R.N. 3rd, Rosenbaum M.W., Pitman M.B. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Cancer Cytopathol. 2022; 130 (3): 195–201. https://doi.org/10.1002/cncy.22514

65. Serinelli S., Khurana K.K. Intraductal papillary mucinous neoplasms of the pancreas: cytologic-histologic correlation study and evaluation of the cytologic accuracy in identifying highgrade dysplasia/invasive adenocarcinoma. Cytojournal. 2024; 21: 6. https://doi.org/10.25259/Cytojournal_71_2023

66. Sinha S.R., Mondal S., Akhtar M.J., Singh R.K., Prakash P. Evaluating carcinoembryonic antigen and glucose levels in pancreatic cyst fluid for mucinous versus non-mucinous differentiation. Cureus. 2024; 16 (6): e62686. https://doi.org/10.7759/cureus.62686

67. Koshel A.P., Drozdov E.S., Dibina T.V., Klokov S.S., Mironova E.B., Rakina Yu.Yu. Combined method for differential diagnosis of pancreatic cystic neoplasm. Siberian Journal of Oncology. 2018; 17 (6): 27–34. https://doi.org/10.21294/1814-4861-2018-17-6-27-34 (In Russian)

68. Bedi M.M., Gandhi M.D., Jacob G., Lekha V., Venugopal A., Ramesh H. CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J. Gastroenterol. 2009; 28 (1): 24–27. https://doi.org/10.1007/s12664-009-0005-4

69. Haglund C., Lundin J., Kuusela P., Roberts P.J. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br. J. Cancer. 1994; 70 (3): 487–492. https://doi.org/10.1038/bjc.1994.332

70. Shibata H., Ohike N., Norose T., Isobe T., Suzuki R., Imai H., Shiokawa A., Aoki T., Murakami M., Mizukami H., Tanaka J.I., Takimoto M. Mucinous cystic neoplasms lined by abundant mucinous epithelium frequently involve KRAS mutations and malignant progression. Anticancer Res. 2017; 37 (12): 7063–7068. https://doi.org/10.21873/anticanres.12178

71. Conner J.R., Mariño-Enríquez A., Mino-Kenudson M., Garcia E., Pitman M.B., Sholl L.M., Srivastava A., Doyle L.A. Genomic characterization of low- and high-grade pancreatic mucinous cystic neoplasms reveals recurrent KRAS alterations in "high-risk" lesions. Pancreas. 2017; 46 (5): 665–671. https://doi.org/10.1097/MPA.0000000000000805

72. Sakhdari A., Moghaddam P.A., Ok C.Y., Walter O., Tomaszewicz K., Caporelli M.L., Meng X., LaFemina J., Whalen G., Belkin E., Zivny J., Wassef W., Woda B.A., Hutchinson L.M., Cosar E.F. Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool. Oncotarget. 2019; 10 (40): 4026–4037. https://doi.org/10.18632/oncotarget.26999

73. Jang K.T., Park S.M., Basturk O., Bagci P., Bandyopadhyay S., Stelow E.B., Walters D.M., Choi D.W., Choi S.H., Heo J.S., Sarmiento J.M., Reid M.D., Adsay V. Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma: implications for management and prognosis. Am. J. Surg. Pathol. 2015; 39 (2): 179–187. https://doi.org/10.1097/PAS.0000000000000357

74. Yamao K., Yanagisawa A., Takahashi K., Kimura W., Doi R., Fukushima N., Ohike N., Shimizu M., Hatori T., Nobukawa B., Hifumi M., Kobayashi Y., Tobita K., Tanno S., Sugiyama M., Miyasaka Y., Nakagohri T., Yamaguchi T., Hanada K., Abe H., Tada M., Fujita N., Tanaka M. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan Pancreas Society. Pancreas. 2011; 40 (1): 67–71. https://doi.org/10.1097/MPA.0b013e3181f749d3

75. Prabhakar L.P., Orchard T.F., Hughes S., van Heerden J.A., DiMagno E.P. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann. Surg. 2000; 231 (2): 205–212. https://doi.org/10.1097/00000658-200002000-00009

76. Munigala S., Gelrud A., Agarwal B. Risk of pancreatic cancer in patients with pancreatic cyst. Gastrointest. Endosc. 2016; 84 (1): 81–86. https://doi.org/10.1016/j.gie.2015.10.030

77. Paklina O.V., Setdikovа G.R., Chekmaryova I.A. Morphological characteristic of pancreatic cystic tumors. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2012; 17 (1): 26–34. (In Russian)

78. Kuboki Y., Shimizu K., Hatori T., Yamamoto M., Shibata N., Shiratori K., Furukawa T. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2015; 44 (2): 227–235. https://doi.org/10.1097/MPA.0000000000000253

79. Furukawa T., Kuboki Y., Tanji E., Yoshida S., Hatori T., Yamamoto M., Shibata N., Shimizu K., Kamatani N., Shiratori K. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci. Rep. 2011; 1: 161. https://doi.org/10.1038/srep00161

80. Jais B., Rebours V., Malleo G., Salvia R., Fontana M., Maggino L., Bassi C., Manfredi R., Moran R., Lennon A.M., Zaheer A., Wolfgang C., Hruban R., Marchegiani G., Fernández Del Castillo C., Brugge W., Ha Y., Kim M.H., Oh D., Hirai I., Kimura W., Jang J.Y., Kim S.W., Jung W., Kang H., Song S.Y., Kang C.M., Lee W.J., Crippa S., Falconi M., Gomatos I., Neoptolemos J., Milanetto A.C., Sperti C., Ricci C., Casadei R., Bissolati M., Balzano G., Frigerio I., Girelli R., Delhaye M., Bernier B., Wang H., Jang K.T., Song D.H., Huggett M.T., Oppong K.W., Pererva L., Kopchak K.V., Del Chiaro M., Segersvard R., Lee L.S., Conwell D., Osvaldt A., Campos V., Aguero Garcete G., Napoleon B., Matsumoto I., Shinzeki M., Bolado F., Fernandez J.M., Keane M.G., Pereira S.P., Acuna I.A., Vaquero E.C., Angiolini M.R., Zerbi A., Tang J., Leong R.W., Faccinetto A., Morana G., Petrone M.C., Arcidiacono P.G., Moon J.H., Choi H.J., Gill R.S., Pavey D., Ouaïssi M., Sastre B., Spandre M., De Angelis C.G., Rios-Vives M.A., Concepcion-Martin M., Ikeura T., Okazaki K., Frulloni L., Messina O., Lévy P. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016; 65 (2): 305–312. https://doi.org/10.1136/gutjnl-2015-309638

81. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., Centeno B.A., Szydlo T., Regan S., del Castillo C.F., Warshaw A.L. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126 (5): 1330– 1336. https://doi.org/10.1053/j.gastro.2004.02.013

82. Cizginer S., Turner B., Bilge A.R., Karaca C., Pitman M.B., Brugge W.R. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011; 40 (7): 1024–1028. https://doi.org/10.1097/MPA.0b013e31821bd62f

83. Ribaldone D.G., Bruno M., Gaia S., Cantamessa A., Bragoni A., Caropreso P., Sacco M., Fagoonee S., Saracco G.M., De Angelis C. Differential diagnosis of pancreatic cysts: a prospective study on the role of intra-cystic glucose concentration. Dig. Liver Dis. 2020; 52 (9): 1026–1032. https://doi.org/10.1016/j.dld.2020.06.038

84. Mohan B.P., Madhu D., Khan S.R., Kassab L.L., Ponnada S., Chandan S., Facciorusso A., Crino S.F., Barresi L., McDonough S., Adler D.G. Intracystic glucose levels in differentiating mucinous from nonmucinous pancreatic cysts: a systematic review and meta-analysis. J. Clin. Gastroenterol. 2022; 56 (2): e131–e136. https://doi.org/10.1097/MCG.0000000000001507

85. Jeon J.H., Kim J.H., Joo I., Lee S., Choi S.Y., Han J.K. Transabdominal ultrasound detection of pancreatic cysts incidentally detected at CT, MRI, or endoscopic ultrasound. AJR Am. J. Roentgenol. 2018; 210 (3): 518–525. https://doi.org/10.2214/AJR.17.18449

86. Stern L., Schuette M., Goetz M.R., Nitschke C., Bardenhagen J., Scognamiglio P., Stüben B.O., Calavrezos L., Amin T., Heumann A., Lohse A.W., de Heer G., Izbicki J.R., Uzunoglu F.G. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery. HPB (Oxford). 2024; 26 (1): 117–124. https://doi.org/10.1016/j.hpb.2023.09.003

87. Egorov V.I., Vishnevskiy V.A., Shchegolev A.I., Karmazanovsky G.G., Shevchenko T.V., Iashina N.I., Dubova E.A., Plotnikova L.S., Melekhina O.V., Kozyrin I.A. Pancreatic resections in treatment of intraductal noninvasive papillary mucinous tumors. Pirogov Russian Journal of Surgery. 2009; 3: 53–60. (In Russian)

88. Choi S.H., Park S.H., Kim K.W., Lee J.Y., Lee S.S. Progression of unresected intraductal papillary mucinous neoplasms of the pancreas to cancer: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2017; 15 (10): 1509–1520.e4. https://doi.org/10.1016/j.cgh.2017.03.020

89. Lensing R.J., Bipat S. Incidences of pancreatic malignancy and mortality in patients with untreated branch-duct intraductal papillary mucinous neoplasms undergoing surveillance: a systematic review. Pancreas. 2017; 46 (9): 1098–1110. https://doi.org/10.1097/MPA.0000000000000907

90. Lee S.W., Shim S.R., Jeong S.Y., Kim S.J. Comparison of preoperative imaging modalities for the assessment of malignant potential of pancreatic cystic lesions: a network meta-analysis. Clin. Nucl. Med. 2022; 47 (10): 849–855. https://doi.org/10.1097/RLU.0000000000004323

91. Wood L.D., Adsay N.V., Basturk O., Brosens L.A.A., Fukushima N., Hong S.M., Kim S.J., Lee J.W., Luchini C., Noë M., Pitman M.B., Scarpa A., Singhi A.D., Tanaka M., Furukawa T. Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms. Pancreatology. 2023; 23 (7): 878–891. https://doi.org/10.1016/j.pan.2023.08.002

92. Frankel T.L., LaFemina J., Bamboat Z.M., D'Angelica M.I., DeMatteo R.P., Fong Y., Kingham T.P., Jarnagin W.R., Allen P.J. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxford). 2013; 15 (10): 814–821. https://doi.org/10.1111/hpb.12137

93. Li S.Y., Wang Z.J., Pan C.Y., Wu C., Li Z.S., Jin Z.D., Wang K.X. Comparative performance of endoscopic ultrasoundbased techniques in patients with pancreatic cystic lesions: a network meta-analysis. Am. J. Gastroenterol. 2023; 118 (2): 243–255. https://doi.org/10.14309/ajg.0000000000002088

94. Ohno E., Balduzzi A., Hijioka S., De Pastena M., Marchegiani G., Kato H., Takenaka M., Haba S., Salvia R. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): a systematic review. Pancreatology. 2024; 24 (1): 48–61. https://doi.org/10.1016/j.pan.2023.12.002

95. Nilsson L.N., Keane M.G., Shamali A., Millastre Bocos J., Marijinissen van Zanten M., Antila A., Verdejo Gil C., Del Chiaro M., Laukkarinen J. Nature and management of pancreatic mucinous cystic neoplasm (MCN): a systematic review of the literature. Pancreatology. 2016; 16 (6): 1028–1036. https://doi.org/10.1016/j.pan.2016.09.011

96. Reid M.D., Choi H.J., Memis B., Krasinskas A.M., Jang K.T., Akkas G., Maithel S.K., Sarmiento J.M., Kooby D.A., Basturk O., Adsay V. Serous neoplasms of the pancreas: a clinicopathologic analysis of 193 cases and literature review with new insights on macrocystic and solid variants and critical reappraisal of so-called “serous cystadenocarcinoma”. Am. J. Surg. Pathol. 2015; 39 (12): 1597–1610. https://doi.org/10.1097/PAS.0000000000000559

97. Tsvirkun V.V., Buriev I.M., Glabay V.P. The resolution of the XVI International Conference of Surgeon Hepatologists of SIS Countries, Ekaterinburg, 2009. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2009; 14 (4): 112–115. (In Russian)

98. Roch A.M., Ceppa E.P., DeWitt J.M., Al-Haddad M.A., House M.G., Nakeeb A., Schmidt C.M. International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative. HPB (Oxford). 2014; 16 (10): 929–935. https://doi.org/10.1111/hpb.12305

99. Tyutyunnik P., Klompmaker S., Lombardo C., Lapshyn H., Menonna F., Napoli N., Wellner U., Izrailov R., Baychorov M., Besselink M.G., Abu Hilal M., Fingerhut A., Boggi U., Keck T., Khatkov I. European Consortium on Minimally Invasive Pancreatic Surgery. Learning curve of three European centers in laparoscopic, hybrid laparoscopic, and robotic pancreatoduodenectomy. Surg. Endosc. 2022; 36 (2): 1515–1526. https://doi.org/10.1007/s00464-021-08439-5

100. Karmazanovsky G.G. MDCT and MRI diagnostics of pancreatic cystic tumors (lecture). Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2012; 17 (1): 11–16. (In Russian)

101. Neoptolemos J.P., Palmer D.H., Ghaneh P., Psarelli E.E., Valle J.W., Halloran C.M., Faluyi O., O'Reilly D.A., Cunningham D., Wadsley J., Darby S., Meyer T., Gillmore R., Anthoney A., Lind P., Glimelius B., Falk S., Izbicki J.R., Middleton G.W., Cummins S., Ross P.J., Wasan H., McDonald A., Crosby T., Ma Y.T., Patel K., Sherriff D., Soomal R., Borg D., Sothi S., Hammel P., Hackert T., Jackson R., Büchler M.W. European Study Group for Pancreatic Cancer. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017; 389 (10073): 1011–1024. https://doi.org/10.1016/S0140-6736(16)32409-6

102. Conroy T., Hammel P., Hebbar M., Ben Abdelghani M., Wei A.C., Raoul J.L., Choné L., Francois E., Artru P., Biagi J.J., Lecomte T., Assenat E., Faroux R., Ychou M., Volet J., Sauvanet A., Breysacher G., Di Fiore F., Cripps C., Kavan P., Texereau P., Bouhier-Leporrier K., Khemissa-Akouz F., Legoux J.L., Juzyna B., Gourgou S., O'Callaghan C.J., Jouffroy-Zeller C., Rat P., Malka D., Castan F., Bachet J.B. Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 2018; 379 (25): 2395–2406. https://doi.org/10.1056/NEJMoa1809775.